Usage of gonadotropins in assisted reproductive technologies significantly improves outcomes

Links shared publicly online about this topic.

1,328
total visits

Usage of gonadotropins in assisted reproductive technologies significantly improves outcomes

The U.S. infertility specialty has empirically incorporated greater amounts of human menopausal gonadotropin (hMG) into stimulation protocols, according to a new review article, "Gonadotropins in the Treatment of Infertility" by George T. Koulianos, MD, published in a recent issue of US Obstetrics & Gynecology, supported by an educational grant from Ferring Pharmaceuticals. The article reviews the wealth of clinical evidence supporting this trend, and demonstrates how t

View full resource at news-medical.net

Tags: Infertility, Pharma, Obstetrics & Gynecology, Education